Neurogene Inc (NGNE) returns
Neurogene returns over 10 years
$1,000 invested in Neurogene ten years ago was worth $129.83 at the close on October 30, 2026, with dividends reinvested: an average return of -18.5% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -1.0% | — | $990.30 | -0.9% |
| 3 months | -18.0% | — | $819.94 | +2.1% |
| Year to date | +33.7% | — | $1,337 | +11.7% |
| 1 year | -16.9% | — | $831.32 | +12.4% |
| 3 years | +107.5% | +27.5% | $2,075 | +88.5% |
| 5 years | -81.2% | -28.4% | $187.93 | +76.0% |
| 10 years | -87.0% | -18.5% | $129.83 | +316.6% |
Neurogene return by calendar year
| Year | NGNE | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +33.7% | +11.7% | +22.0% |
| 2025 | -9.9% | +17.7% | -27.6% |
| 2024 | +18.0% | +24.9% | -6.9% |
| 2023 | +90.4% | +26.2% | +64.2% |
| 2022 | -89.4% | -18.2% | -71.3% |
| 2021 | -65.8% | +28.7% | -94.6% |
| 2020 | +14.4% | +18.4% | -3.9% |
| 2019 | +470.4% | +31.2% | +439.1% |
| 2018 | -81.6% | -4.6% | -77.1% |
| 2017 | -28.8% | +21.7% | -50.5% |
| 2016 | +32.3% | +12.0% | +20.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Neurogene Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.